---
title: "Frost Radar™: Clinical Documentation Integrity in North America, 2025"
description: A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
image: https://go.frost.com/hubfs/Images/2025/HLS/GO/KAC4/D01_HLS_FR_KAC4_ClinicalDocumentation_062625_800x400_MK_HK.jpg
---

![Clinical Documentation](https://go.frost.com/hs-fs/hubfs/Images/2025/HLS/GO/KAC4/D01_HLS_FR_KAC4_ClinicalDocumentation_062625_2500x500_MK_HK.jpg?width=2000&height=400&name=D01_HLS_FR_KAC4_ClinicalDocumentation_062625_2500x500_MK_HK.jpg "Clinical Documentation")

*Discover the Future of Clinical Documentation: Frost Radar™ 2025 Identifies the CDI Leaders Redefining Healthcare*

Why This Analysis Matters

As healthcare shifts from fee-for-service to value-based models, Clinical Documentation Integrity (CDI) has emerged as a strategic pillar. More than just a compliance tool, CDI now plays a key role in improving care quality, boosting operational efficiency, and ensuring reimbursement accuracy.

This Frost & Sullivan analysis brings you a first look at the vendors driving the next wave of CDI transformation.

[ Instant Access ](https://store.frost.com/frost-radar-clinical-documentation-integrity-in-north-america-2025.html?utm_source=hs_email&utm_medium=email&utm_term=GL_OU_HLS_FR_KAC4_RD1_Jul25&utm_campaign=HLS01_TG12_KAC4_Jul25)

What’s Inside the Frost Radar™ Analysis?

In this exclusive 2025 edition of the Frost Radar™, we:

- Benchmarked 120+ vendors and spotlighted the top 11 industry leaders
- Evaluated innovation across AI, ambient scribing, NLP, and autonomous coding
- Scored vendors on growth, scalability, and tech strategy
- Provided tactical insights for providers, partners, and investors shaping the CDI roadmap

### Download Sample

Top Companies to Watch

Featured vendors include:

- **Microsoft** – Leading with ambient AI and cloud-native CDI tools
- **Optum** – Pioneering enterprise-scale NLP and clinical intelligence
- **Oracle Health, Solventum, Iodine Software, Arintra** – Redefining automation and provider experience

Whether you are building a next-gen CDI tech stack, exploring partnerships, or seeking to stay ahead of the curve, this analysis offers strategic clarity for your next move.

Strategic Insights You Will Gain

### **Technology Intelligence**

•    First-in-human milestones (e.g., ChampioNIR, Esprit BTK)

•    R3 Vascular’s IDE-backed MAGNITUDE trial

•    Positive long-term results from Abbott’s bioresorbable portfolio

### **Opportunities to Act On**

•    Growth in below-the-knee interventions for **chronic limb-threatening ischemia (CLTI)**

•    Clinical adoption in **ambulatory surgical centers (ASCs)**

•    Innovation gaps in **resorbable scaffolds** and **device-drug synergy**

### **Competitive Landscape**

•    Market share and positioning of Boston Scientific, Abbott, BD, Medtronic, and emerging disruptors

•    Strategic M&A activity: Acotec, Cardiovascular Systems Inc.

### Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on [store.frost.com](https:/store.frost.com?utm_source=hslinks).

[ Talk to our experts today! ](https://insights.frost.com/gpdialog?hsCtaTracking=2540db65-be35-44dd-abb4-f667210b0fde%7C973ed019-8950-4e26-8c86-4b58d2df9b85&hsLang=en)

*$1,000 honorarium is subject to eligibility

![drive-growth-image-scaled-2](https://go.frost.com/hubfs/Imported%20sitepage%20images/drive-growth-image-scaled-2.jpg "drive-growth-image-scaled-2")

**